Bayer CropScience Ltd. | Large-cap | Basic Materials
₹5,750.00
1.69%
| Bayer CropScience Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 54.7B
Gross Profit 20.7B 37.90%
Operating Income 6.0B 11.05%
Net Income 5.7B 10.38%

Balance Sheet Metrics

Total Assets 52.5B
Total Liabilities 24.0B
Shareholders Equity 28.5B
Debt to Equity 0.84

Cash Flow Metrics

Operating Cash Flow -2.3B
Free Cash Flow 2.2B

Revenue & Profitability Trend

Bayer CropScience Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 54.7B 48.9B 49.4B 45.8B 41.4B
Cost of Goods Sold 34.0B 29.4B 28.5B 26.8B 24.6B
Gross Profit 20.7B 19.5B 20.9B 18.9B 16.8B
Operating Expenses 9.4B 7.1B 7.9B 7.4B 6.0B
Operating Income 6.0B 9.1B 8.6B 7.6B 7.5B
Pre-tax Income 7.1B 9.4B 9.9B 8.5B 7.9B
Income Tax 1.4B 2.0B 2.3B 2.0B 3.0B
Net Income 5.7B 7.4B 7.6B 6.5B 4.9B
EPS (Diluted) - ₹164.77 ₹168.71 ₹143.58 ₹109.72

Income Statement Trend

Bayer CropScience Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 44.7B 39.1B 39.0B 35.8B 35.4B
Non-Current Assets 7.7B 6.9B 7.8B 7.8B 7.0B
Total Assets 52.5B 46.0B 46.8B 43.5B 42.4B
Liabilities
Current Liabilities 22.2B 16.0B 17.8B 16.6B 15.7B
Non-Current Liabilities 1.7B 1.5B 1.9B 1.7B 1.2B
Total Liabilities 24.0B 17.5B 19.7B 18.3B 16.9B
Equity
Total Shareholders Equity 28.5B 28.5B 27.1B 25.2B 25.5B

Balance Sheet Composition

Bayer CropScience Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 7.1B 9.4B 9.9B 8.5B 7.9B
Operating Cash Flow -2.3B 13.0B 6.5B 2.3B 3.4B
Investing Activities
Capital Expenditures -400.0M -394.0M -726.0M -473.0M -312.0M
Investing Cash Flow 389.0M -300.0M 581.0M 211.0M -211.0M
Financing Activities
Dividends Paid -5.6B -6.1B -5.6B -6.7B -5.2B
Financing Cash Flow -5.6B -6.1B -5.6B -6.7B -5.3B
Free Cash Flow 2.2B 9.1B 5.3B 1.6B 6.4B

Cash Flow Trend

Bayer CropScience Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 43.55
Forward P/E 27.25
Price to Book 8.69
Price to Sales 4.53

Profitability Ratios

Profit Margin 10.38%
Operating Margin 13.05%
Return on Equity 19.93%
Return on Assets 7.68%

Financial Health

Current Ratio 2.01
Debt to Equity 3.69
Beta 0.22

Per Share Data

EPS (TTM) ₹126.55
Book Value per Share ₹634.13
Revenue per Share ₹1,217.83

Financial data is updated regularly. All figures are in the company's reporting currency.